Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × X-Rays × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 5 Wilms Tumor 4 Rhabdoid Tumor 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Neuroblastoma 4 Medulloblastoma 4 Histiocytosis, Langerhans-Cell 4 Hepatoblastoma 4 Glioma 4 Ependymoma 4 Sarcoma 3 Rhabdomyosarcoma 3 Osteosarcoma 3 Central Nervous System Neoplasms 3 Sarcoma, Ewing 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroendocrine Tumors 2 Malignant Solid Neoplasm 2 Lymphoma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Thyroid Neoplasms 1 Thrombosis 1 Prostatic Neoplasms 1

Interventions

Ipilimumab 75 pembrolizumab 68 Nivolumab 67 aldesleukin 44 Cyclophosphamide 43 Interleukin-2 32 fludarabine phosphate 29 Vemurafenib 28 Dacarbazine 27 fludarabine 24 trametinib 23 dabrafenib 23 Temozolomide 20 Bevacizumab 15 Radiosurgery 13 Paclitaxel 12 Introns 11 Interferon alpha-2 11 Carboplatin 11 binimetinib 10 CTLA-4 Antigen 10 Radiotherapy 9 talimogene laherparepvec 8 peginterferon alfa-2b 8 montanide ISA 51 8 encorafenib 8 cobimetinib 8 Sorafenib 8 spartalizumab 7 poly ICLC 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡